Cynapsus Therapeutics cynapsus.ca


Public lists: Pharma Startups (4732)

Cynapsus (NASDAQ: CYNA) (TSX: CTH) is a specialty pharmaceutical company developing an improved dosing formulation of an approved drug used to treat the motor symptoms of Parkinson's disease. Cynapsus is developing a fast-acting, easy-to-use, sublingual thin film for the potential treatment for on-demand management of debilitating OFF episodes associated with Parkinson's disease (PD). The Company successfully completed a Phase 2 clinical trial for its product candidate, APL-130277, a sublingual ...Show all

Cynapsus (NASDAQ: CYNA) (TSX: CTH) is a specialty pharmaceutical company developing an improved dosing formulation of an approved drug used to treat the motor symptoms of Parkinson's disease. Cynapsus is developing a fast-acting, easy-to-use, subling...Show all

Company (Acquired)

Phone: 416-703-2449

Fax:

828 Richmond Street West

Toronto, M6J 1C9
Ontario, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cynapsus Therapeutics $0M Aug 31, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cynapsus Therapeutics Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Sublingual apomorphine Dec 16, 2015 Jun 06, 2017 Patent
Sublingual apomorphine Dec 09, 2015 Jun 06, 2017 Patent
Sublingual apomorphine Dec 09, 2015 Jun 06, 2017 Patent
Sublingual apomorphine Dec 09, 2015 Jun 06, 2017 Patent
Sublingual films Feb 03, 2016 Aug 30, 2016 Patent
See all 12 patents